Rémi Delva
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 7
- Surgery 5
- Testicular diseases and treatments 3
- Urinary and Genital Oncology Studies 1
- Bladder and Urothelial Cancer Treatments 1
- Co-authors
- Gerard Alain Milano (2 shared papers)Jean‐Yves Pierga (2 shared papers)Armelle Degeorges (2 shared papers)Xavier B. Pivot (2 shared papers)Corinne Veyret (3 shared papers)Patricia de Crémoux (2 shared papers)Marie-Christine Étienne-Grimaldi (2 shared papers)Stéphane Culine (4 shared papers)
- Journals
- Annals of Oncology (5 papers)European Urology (2 papers)Breast Cancer Research and Treatment (2 papers)Medical Oncology (1 paper)The Lancet (1 paper)
- Partner nations
- FranceUnited StatesChina
In The Last Decade
Rémi Delva
21 papers receiving 670 citations
Peers
Comparison fields: 5 of 28
- Cancer Research 161
- Oncology 98
- Surgery 171
- Reproductive Medicine 14
- Pharmacology 9
Countries citing papers authored by Rémi Delva
This map shows the geographic impact of Rémi Delva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Delva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Delva more than expected).
Fields of papers citing papers by Rémi Delva
This network shows the impact of papers produced by Rémi Delva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Delva. The network helps show where Rémi Delva may publish in the future.
Co-authors
The 25 scholars most cited alongside Rémi Delva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 146 | |
| 2 | 2010 | 127 | |
| 3 | 2019 | 105 | |
| 4 | 2005 | 88 | |
| 5 | 2010 | 61 | |
| 6 | 2011 | 48 | |
| 7 | 2013 | 38 | |
| 8 | 2014 | 18 | |
| 9 | 2019 | 15 | |
| 10 | 2023 | 11 | |
| 11 | 2005 | 10 | |
| 12 | 2005 | 7 | |
| 13 | 2011 | 6 | |
| 14 | 1995 | 5 | |
| 15 | 2006 | 4 | |
| 16 | 2006 | 3 | |
| 17 | rIL-2 in metastatic soft tissue sarcomas refractory to chemotherapy: response and enhancement of further chemosensitivity. | 1999 | 2 |
| 18 | [Isolated peritoneal metastases from an lobular infiltrating breast carcinoma. Value of laparoscopy]. | 1998 | 1 |
| 19 | 2010 | 1 | |
| 20 | 2018 | 1 |
About Rémi Delva
Rémi Delva is a scholar working on Cancer Research, Surgery, Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 698 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Testicular diseases and treatments (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Urinary and Genital Oncology Studies (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Brain Metastases and Treatment (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Cancer Research (161 citations), Oncology (98 citations), Surgery (171 citations), Reproductive Medicine (14 citations) and Pharmacology (9 citations). Rémi Delva has collaborated with scholars based in France, United States and China. Frequent co-authors include Gerard Alain Milano, Jean‐Yves Pierga, Armelle Degeorges, Xavier B. Pivot, Corinne Veyret, Patricia de Crémoux, Marie-Christine Étienne-Grimaldi, Stéphane Culine, Armelle Caty and Pierre Kerbrat. Their work appears in journals such as Annals of Oncology, European Urology, Breast Cancer Research and Treatment, Medical Oncology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.